# Wegovy Reduces BMI in Kids With Obesity as Young as 6

Source: [MedPageToday.com - medical news for physicians](https://www.medpagetoday.com/meetingcoverage/obesityweek/123910) · 2026-11-16 · Medicine
Page: https://themorning.science/story/wegovy-reduces-bmi-in-kids-with-obesity-as-young-as-6-27e00ee6e9de7a79
Kind: research · Impact: medium

## In brief

- Results from the phase III STEP Young trial show children ages 6 to 11 with obesity lost significant weight on semaglutide (Wegovy).
- The results were presented at ObesityWeek in National Harbor, Md.
- Reported results are from the trial at week 68, measuring mean change in body mass index (BMI).

## Why it matters

It provides trial evidence on a GLP-1 medication for obesity in children as young as 6, an age group with limited drug-trial data.

## Timeline

- 2026-11-16: Phase III STEP Young trial results on Wegovy in children aged 6 to 11 presented at ObesityWeek

## Coverage

- [Wegovy Reduces BMI in Kids With Obesity as Young as 6](https://www.medpagetoday.com/meetingcoverage/obesityweek/123910) — MedPageToday.com - medical news for physicians, 2026-11-16

Tags: obesity, semaglutide, pediatrics, glp-1, clinical-trial

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
